e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
Airway and parenchymal diseases in occupational and environmental lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low-molecular weight agents inducing airway sensitization via skin exposure: a systematic review of experimental models
H. TSUI (Leuven, Belgium), S. Ronsmans (Centre , Belgium), L. De Sadeleer (Centre , Belgium), P. Hoet (Centre , Belgium), J. Vanoirbeek (Centre , Belgium), B. Nemery (Centre , Belgium)
Source:
International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases
Session:
Airway and parenchymal diseases in occupational and environmental lung diseases
Session type:
Poster Discussion
Number:
5240
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. TSUI (Leuven, Belgium), S. Ronsmans (Centre , Belgium), L. De Sadeleer (Centre , Belgium), P. Hoet (Centre , Belgium), J. Vanoirbeek (Centre , Belgium), B. Nemery (Centre , Belgium). Low-molecular weight agents inducing airway sensitization via skin exposure: a systematic review of experimental models. 5240
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Comparative airway response to high- versus low-molecular weight agents in occupational asthma
Source: Eur Respir J 2009; 33: 734-739
Year: 2009
Predictors of patterns of response following specific inhalation challenge testing with low molecular weight agents.
Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways
Year: 2018
LATE-BREAKING ABSTRACT: Advantageous therapeutic effects of a GATA-3-specific DNAzyme in comparison to corticosteroid treatment in animal models of allergic airway inflammation
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Comparison between airway response to high versus low molecular weight agents in occupational asthma
Source: Annual Congress 2010 - Occupational asthma
Year: 2010
New-onset work-related airway symptoms in workers exposed to high molecular weight (HMW) agents are predicted by clinical markers of airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 509s
Year: 2001
Repeated exposure to organic material alters inflammatory and physiological airway responses
Source: Eur Respir J 2009; 34: 80-88
Year: 2009
Paracetamol use and asthma: an overview of evidence implicating adult exposure
Source: Annual Congress 2012 - Paracetamol and asthma: a causal link?
Year: 2012
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013
The new paradigm: assessing airway inflammation rather than diagnostic labelling is a movement not a fad
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006
Usefulness of physiological tests of small airways function in diagnosing asthma: a systematic review
Source: Virtual Congress 2020 – Lung function diagnostics
Year: 2020
Is there persistent airway inflammation years after removal from exposure to an agent causing occupational asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 509s
Year: 2001
Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009
A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept